Fanti S.; Ambrosini V.; Tomassetti P.; Castellucci P.; Montini G.; Allegri V.; Grassetto G.; Rubello D.; Nanni C.; Franchi R., Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET., «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2008, 62(10), pp. 667 - 671 [Scientific article]
Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A;
Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M., Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)., «THE LANCET ONCOLOGY», 2008, 9, pp. 352 - 358 [Scientific article]
Ambrosini V.; Rubello D.; Nanni C.; Al-Nahhas A.; Fanti S., Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients, «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29, pp. 415 - 417 [Scientific article]
Pantaleo MA;Nannini M;Lopci E;Castellucci P;Maleddu A;Lodi F;Nanni C;Allegri V;Astorino M;Brandi G;Di Battista M;Boschi S;Fanti S;Biasco G, Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases., «INTERNATIONAL JOURNAL OF ONCOLOGY», 2008, 33, pp. 443 - 452 [Scientific article]
Brandi G; Nannini M; Pantaleo MA; Fanello S; Farsad M; Fanti S; Ercolani G; Maleddu A; Di Battista M; Biasco G., Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients., «CHEMOTHERAPY», 2008, 54(6), pp. 421 - 424 [Scientific article]
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A., Oncologic PET tracers beyond [18F]FDG and the novel quantitative approaches in PET imaging., «THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 52(1), pp. 50 - 65 [Scientific article]
Alavi A.; Fanti S., PET imaging in endocrine disorders
PET clinics, PHILADELPHIA, W.B. Saunders Company, 2008, pp. 240 (Elsevier). [Research monograph]
Prasad V.; Ambrosini V.; Alavi A.; Fanti S.; Baum R.P., PET/CT in Neuroendocrine Tumors: evaluation of receptor status and metabolism, in: TORIGIAN D.A. ALAVI A., PET/CT and PET/MRI for assessment of structural and functional Relationships in Disease Conditions, PHILADELPHIA, W.B. Sauders Company, 2008, pp. 355 - 379 [Chapter or essay]
Farsad M; Schiavina R; Franceschelli A; Sanguedolce F; Castellucci P; Bertaccini A; Brunocilla E; Manferrari F; Concetti S; Garofalo M; Rocca C; Borghesi M; Franchi R; Fanti S; Nanni C; Martorana G., POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER, «DISEASE MARKERS. SECTION A, CANCER BIOMARKERS», 2008, 4, pp. 277 - 284 [Scientific article]
Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL., Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma., «CANCER», 2008, 113(9), pp. 2496 - 2503 [Scientific article]
Lodi F.; Rizzello A.; Trespidi S.; Di Pierro D.; Marengo M.; Farsad M.; Fanti S.; Al-Nahhas A.; Rubello D.; Boschi S., Reliability and reproducibility of N-[11C]methyl-choline and L-(S-methyl-[11C])methionine solid-phase synthesis: a useful and suitable method in clinical practice., «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29(8), pp. 736 - 740 [Scientific article]
Ruffato A; Pilotti V; Fanti S; Catellucci P; Golemi A; Galassi R; Moretti A; Mattioli S., Sensibility and specificity of FDG PET/CT for preoperative staging of esophageal cancer, «INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY», 2008, 7 (Suppl. 2), pp. S186: 141-P - S186: 141-P [Abstract]
Marangoni A.; Donati M.; Nanni C.; di Pierro D.; Rizzello A.; Trespidi S.; Aldini R.; Pignanelli S.; Fanti S.; Cevenini R., Small Animal PET in the mouse model of Chlamydia muridarum infection., in: GUNNA CHRISTIANSEN, Proceedings of VIth Meeting of the European Society for Chlamydia Research., AARHUS, University of Aarhus, 2008, pp. 33 - 33 (atti di: VIth Meeting of the European Society for Chlamydia Research., Aarhus, 1st-4th July, 2008.) [Abstract]
Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD., The role of (18)F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study., «EUROPEAN JOURNAL OF SURGICAL ONCOLOGY», 2008, 34, pp. 581 - 586 [Scientific article]
A. Galuppi; M. La Macchia; S. Medoro; A. Pepe; F. Romani; P. De Iaco; P. Castellucci; S. Fanti; E. Salizzoni; M. Coe; E. Barbieri, The use of pet/tc in the treatment planning of locally advanced cervical cancer, in: , «TUMORI», 2008, 7 suppl. 2, pp. s119 - s119 (atti di: XVIII Congresso Nazionale AIRO, Milano, 15-18 novembre 2008) [Abstract]
